To evaluate the possible role of functional eIF-5A as a potential therapeutic target in glioblastomas, we treated tumor derived cell lines with GC7, a well established specific inhibitor of desoxyhypusine synthase (DHS), and compared its antiproliferative effect to treated primary astrocytes. This evidence concerns the gene DHPS and neoplasm.